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The Clinical Outcomes of Transcatheter
Microcoil Embolization in Patients with
Active Lower Gastrointestinal Bleeding in
the Small Bowel
Objective: To assess the clinical outcomes of the transcatheter microcoil
embolization in patients with active lower gastrointestinal (LGI) bleeding in the
small bowel, as well as to compare the mortality rates between the two groups
based on the visualization or non-visualization of the bleeding focus determined
by an angiography.
Materials and Methods: We retrospectively evaluated all of the consecutive
patients who underwent an angiography for treatment of acute LGI bleeding
between January 2003 and October 2007. In total, the study included 36 patients
who underwent a colonoscopy and were diagnosed to have an active bleeding in
the LGI tracts. Based on the visualization or non-visualization of the bleeding
focus, determined by an angiography, the patients were classified into two
groups. The clinical outcomes included technical success, clinical success (no
rebleeding within 30 days), delayed rebleeding (> 30 days), as well as the major
and minor complication rates.
Results: Of the 36 patients, 17 had angiography-proven bleeding that was dis-
tal to the marginal artery. The remaining 19 patients did not have a bleeding focus
based on the angiography results. The technical and clinical success rates of per-
forming transcatheter microcoil embolizations in patients with active bleeding
were 100% and 88%, respectively (15 of 17). One patient died from continued
LGI bleeding and one patient received surgery to treat the continued bleeding.
There was no note made on the delayed bleeding or on the major or minor com-
plications. Of the 19 patients without active bleeding, 16 (84%) did not have
recurrent bleeding. One patient died due to continuous bleeding and multi-organ
failure.
Conclusion: The superselective microcoil embolization can help successfully
treat patients with active LGI bleeding in the small bowel, identified by the results
of an angiography. The mortality rate is not significantly different between the
patients of the visualization and non-visualization groups on angiography.
he definition of acute lower gastrointestinal (LGI) bleeding is bleeding
with an origin distal to the ligament of Treitz. This phenomenon occurs at
an average annual incidence rate of 20.5 per 100,000 patients (1). The
therapeutic options for patients with massive LGI bleeding include surgery,
vasopressin infusion, endoscopy, and transcatheter embolization. The results from past
studies suggest that patients treated by surgery tend to have a high mortality rate (15-
30%) (2); whereas, patients treated with vasopressin had high rates of complication
and rebleeding (3). Traditionally, an endoscopy is the method of choice to investigate
and treat LGI bleeding, yet it fails in 32% of cases, mainly because of the technical
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e-mail: ymhan@chonbuk.ac.kr Tdifficulties associated with the presence of blood clots,
stool, and the amount of time required to prepare a patient
for a colonoscopy (4, 5). In addition, sources of bleeding in
the small bowel are not accessible via a colonoscopy.
The use of the transcatheter embolization has recently
become a viable option for the management of LGI
bleeding (6-13), especially if the angiography reveals the
bleeding focus in the colon. Even though a patient shows
clinical proof of active LGI bleeding, some patients do not
show the bleeding focus on an angiography (14). To the
best of our knowledge, only a few reports exist on treating
LGI bleeding with a transcatheter microcoil embolization
in the small bowel. Furthermore, even fewer clinical
studies exist about comparing the mortality rates between
the visualization versus the non-visualization groups when
treating small bowel bleeding by transcatheter microcoil
embolization. 
The purpose of our study was to assess the clinical
outcome after performing transcatheter microcoil
embolizations in patients with active LGI bleeding, and
comparing the mortality rates between groups of patients,
defined visualization or non-visualization of the bleeding
focus, respectively, as determined by an angiography. 
MATERIALS AND METHODS
Patient Population
We retrospectively evaluated the clinical records of all
the consecutive patients, diagnosed with acute LGI
bleeding and who underwent an angiography from
January 2003 to October 2007. We obtained a waiver
from the Institutional Review Board for patient consent for
this study. In total, we identified 46 patients who
underwent an angiography for LGI bleeding; however, we
excluded 10 patients due to colonic bleeding with divertic-
ulitis. The remaining 36 patients consisted of 25 men and
11 women (age range: 22 to 80 years, mean age: 62 years).
These patients had clinically active, massive LGI bleeding
as well as suspected small bowel bleeding, evidenced by
active blood clots in the cecal area from the terminal ileum,
and the inability to point out an active bleeding focus in
the entire colon by a colonoscopy. We defined active LGI
bleeding as hematochezia that occurred within 12 hours
before an angiography. We considered massive bleeding to
have occurred if the patients required a transfusion of at
least four units of blood over a 12-hour period in the
hospital, or the patients had hemodynamic instability
(hypotension with a systolic blood pressure < 90 mmHg).
We clinically monitored each patient after an angiography
or embolization for any signs, symptoms or laboratory
evidence of intestinal ischemia or recurrent intestinal
hemorrhage. We performed a colonoscopy to identify
active bleeding in 35 patients and an abdominal computed
tomography (CT) in eight patients prior to an angiography.
We found no evidence of an active bleeding focus on the
CT.
Angiography and Embolization
We performed a right femoral artery puncture using the
manual method, and a 6.0 Fr introducer sheath was
inserted under fluoroscopic guidance. In addition, we
performed a superior and inferior mesenteric angiography
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Fig. 1. Treatment modalities for 36
patients with lower gastrointestinal
hemorrhaging. Tx = treatment, pts =
patients
Angiography: 36 pts
Active bleeding focus: 14 pts No bleeding focus: 22 pts
Continued bleeding: 15 pts
Bleeding scan Conservative Tx
1: death
Positive findings: 7 pts
- reangiography Negative findings: 8 pts
Positive bleeding focus:
3 pts - embolization
No bleeding focus: 4 pts 
No bleeding: 7 pts
Rebleeding: 3 pts
1: re-embolization
1: operation
1: death
Embolizationin each patient utilizing digital subtraction imaging and
selective arterial contrast injections with standard 5-Fr
catheters. We also performed the selective superior
mesenteric artery angiography using different catheter
locations under the following conditions: 15-30 ml of
contrast media and a 300-500 psi injection pressure. This
procedure evaluated the jejunal, ileal, and the ileocolic
branches. After identifying a bleeding site, we performed a
superselective embolization using a 3-Fr coaxial
microcatheter system (Microferret; Cook, Bjaeverskov,
Denmark) with a 0.016-inch guide wire (GT; Terumo,
Tokyo, Japan). We positioned the microcatheter as close as
possible proximal to the marginal artery or the vasa recta
at the bleeding site. We used 3-2 mm or 4-2 mm
microcoils (Tornado embolization microcoil: Cook,
Bloomington, IN) as the embolic agents in all the patients.
If the angiography did not show a bleeding focus, we
performed a provocative test followed by an intraarterial
injection of a vasodilator such as Alprostadil 1 ample 
(
�Eglandin: WelFide Korea, Seoul, Korea) mixed with
normal saline (30 cc). However, some patients who did not
show a bleeding site on the mesenteric angiography
underwent radionuclide scanning with technetium 99m-
labeled red blood cells. If the radionuclide scan showed a
suspected bleeding focus, we then performed a superselec-
tive angiography. If we identified a bleeding focus, we then
performed an embolization. However, patients underwent
conservative treatment if a radionuclide scan did not
reveal a bleeding focus. We performed the embolizations
close to the bleeding site and beyond the marginal artery
or the vasa rectal level. 
Definition and Data Analysis
We analyzed the data according to the definitions and
guidelines outlined for a percutaneous transcatheter
embolization in the Society of Interventional Radiology
(15). We defined technical success as the immediate
cessation of bleeding as identified by a post-procedural
angiography. We defined clinical success as the clinical
cessation of bleeding and the stabilization of hemoglobin
levels that required no more than 2U of packed red blood
cells within 30 days after the procedure. We assessed the
rebleeding by checking the clinical parameters passage of
blood via the rectum and by a hematologic evaluation
requiring more than 2U of packed red blood cells. We
defined ischemic complications based on the outcome of
this analysis. An example of a major ischemic complication
was a bowel infarction that required surgery, whereas
examples of minor ischemic complications were conditions
that resulted in no sequelae and no further treatment.
We analyzed the outcomes and the clinical factors such
as age, gender, cause of bleeding, hemodynamic support,
presence of coagulopathy and mortality and subdivided
the patients for the two subgroups: group A received an
embolization at the bleeding site and group B did not
receive undergo an embolization. If we were not able to
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Fig. 2. Results from 81-year-old woman with acute lower gastrointestinal bleeding.
A. Selective arteriogram, obtained after coaxial advancement of catheter into right ileocolic artery, shows active hemorrhaging (arrow).
B. Branch of right ileocolic artery has been embolized with single 3-2 mm microcoil (arrow).   
C. Postembolization arteriogram after superselective embolization shows total occlusion of feeding vessel and cessation of hemorrhag-
ing.
ABCidentify a bleeding focus on an angiography and a patient
had unstable vital signs, a drop of 2 mg or greater of
hemoglobin levels after transfusion and/or if there was
persistent melena, a surgical procedure was considered.
We performed a Student’s t or Chi-squared test (where
appropriate) to determine if significant differences exist
between the two groups and considered a p value less than
0.05 to be statistically significant. 
RESULTS
The patient treatment algorithm is located in Figure 1.
Upon the initial angiography, 14 patients (39%) had
contrast extravasation in the LGI tract and consequently
underwent a superselective transcatheter microcoil
embolization (Fig. 2). Postembolization rebleeding
occurred in 21% of these patients (3 of 14 patients) within
one day of the embolization. Two patients showed active
bleeding in the small bowel on radionuclide scanning with
technetium 99m-labeled red blood cells and then
underwent re-embolization using microcoils. One patient,
however, continued to bleed (hemoglobin level dropped
from 9 g/dL to 6 g/dL), and, as a result, underwent a
surgical resection of the ileum. Following the resection, we
discovered an ulcerative lesion in the ileum. Of the three
patients with rebleeding, one with gastric cancer had
continuous hematochezia that resulted in the death of the
patient due to disseminated intravascular coagulation five
days after embolization. 
On the initial angiography, 22 patients did not show
contrast extravasation. Next, we performed a provocative
test on these 22 patients, which did not show any bleeding
focus angiography. Next, 15 of the 22 patients underwent
radionuclide scans due to continuous hematochezia. Seven
of the 15 had a suspected bleeding focus in the small bowel
and they subsequently underwent superselective re-
angiography of the superior mesenteric artery. Of the
seven patients, three showed contrast extravasation or a
pseudoaneurysm, and they underwent a superselective
microcoil embolization. We did not observe the contrast
extravasation on the final angiography.
For the 17 patients in group A, we performed a
transcatheter embolization for the treatment of LGI
bleeding in the small bowel, including three patients who
underwent embolizations after performing a bleeding scan
due to the negative findings on the initial angiography. The
technical success rate was 100%; however, the complete
clinical success was only 88% (15 of 17 patients). In
contrast, we performed 19 superior mesenteric artery
branch embolizations: ileocolic artery (n = 12), jejunal
branch (n = 4) and ileal branch (n = 3). The angiography
results revealed either contrast extravasation (n = 18) or a
pseudoaneurysm (n = 1). We used 3-2 mm or 4-2 mm
microcoils as a function of vessel size. Among all of the 17
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Fig. 3. Results from 69-year-old male patient with acute lower gastrointestinal bleeding following surgical treatment of gastric cancer.
A. Superior and inferior mesenteric arteriogram reveals no abnormal extravasation of contrast medium.
B. Radionuclide scan with technetium 99m-labeled red blood cells, performed immediately due to continued bleeding, displays bleeding
focus (arrow) from increased isotope uptake in left lower quadrant. 
C. Repeated angiogram does not show extravasation of contrast medium. Patient underwent conservative management and did not
show any further bleeding one week later.
ABCpatients who achieved complete clinical success, there
were no clinical signs or symptoms of intestinal ischemia
and no case of postembolic infarction. The mortality rate
for the patients who received embolizations due to a
bleeding focus was 6%.
The 19 patients belonging to group B underwent conser-
vative management such as intravenous injections of
vitamin K, vasopressin treatment for three days, and an
intravenous packed red blood cell transfusion. Of the 19
patients 15 showed continuous hematochezia, which led to
radionuclide scans. Although the radionuclide scans
showed a suspected bleeding focus, four patients did not
show additional contrast extravasation on the repeated
angiography (Fig. 3). Of these four patients, three had
continued bleeding. In addition, two of the patients had a
history of taking non-steroidal anti-inflammatory drugs
and consequently did not show the LGI bleeding a week
later. One patient died due to continuous bleeding and
multi-organ failure. The mortality rate for the patients
without a bleeding focus visualized on an angiography was
5%.
The clinical data, including the laboratory findings,
systolic blood pressure and number of transfusions before
angiography for the two groups, revealed that the mortal-
ity rate was not significantly different between the two
groups (Table 1). 
DISCUSSION
The overall mortality rate for upper gastrointestinal
(UGI) bleeding is approximately 14% (16), as opposed to
less than 5% for LGI bleeding (1). Patients with LGI
bleeding can present with various clinical conditions, which
primarily characterized by minor bleeding that can be
treated conservatively. Some patients have severe life-
threatening intermittent bleeding or continual active
bleeding. Patients with life-threatening bleeding or contin-
ual bleeding require examination by CT, colonoscopy,
visceral angiography and/or radionuclide scans to identify
the bleeding focus and administer the proper treatment.
The noninvasive diagnostic tools for investigating acute
hematochezia by evaluating for the presence of a bleeding
focus or the underlying disease include a CT or radionu-
clide scan (17, 18). Kuhle and Sheiman (17) suggested that
the capability of the helical CT to depict acute LGI
bleeding may exceed the lower bleeding limit of 0.5
mL/min, which was cited for the mesenteric angiography.
Recent reports cite the use of a multidetector row helical
CT for patients with acute massive gastrointestinal
bleeding. The sensitivity and specificity were found to be
above 90% (18). In our study, the CT finding did not show
an active bleeding focus. Radionuclide scans can detect
hemorrhaging rates as low as 0.1 mL/min (19). Diehl et al.
(20) reported that 60% of patients (12 out of 20) had
positive findings on radionuclide scans, and eight of the 12
patients underwent surgery. For patients with acute LGI
bleeding and negative or nondiagnostic endoscopy or CT
findings, radionuclide scans improved the overall rate of
bleeding detection. In our study, 20% of patients (3 of 15)
had matching radionuclide scan and angiographic findings. 
An endoscopy is the first step in the diagnosis and
management of UGI and LGI bleeding (4, 5). An
emergency endoscopy for LGI bleeding may be difficult
because stool or blood in the colon may cause an adequate
inspection of the mucosa to be impossible. Although
purging may clear up retained blood and clots, active
bleeding frequently fills up the lumen and this limits the
usefulness of the examination. Moreover, patients need to
be hemodynamically stable and have undergone adequate
colonic preparation to perform a colonoscopy (21). In
addition, a bleeding source in the small bowel does not
Transcatheter Microcoil Embolization of Active Lower GI Bleeding in Small Bowel
Korean J Radiol 10(4), Jul/Aug 2009 395
Table 1. Clinical Characteristics of Visualization and Non-
Visualization Groups
Characteristics Group A (n = 17) Group B (n = 19)
Gender (M/F) 13/4 12/7
Age 65.2 ± 15.9 60.3 ± 15.9
Systolic pressure 105.7 ± 16.80 106.0 ± 18.70
Diagnostic Tool
Colonoscopy 17 18
Bleeding scan 031 2
Comorbidity
Unknown origin 06 05
Cancer 03 03
Hypertension 04 00
NSAIDs 00 04
Diabetes 00 04
After surgery 01 02
Inflammatory bowel disease 01 02
Chronic renal failure 02 00
Liver cirrhosis 02 00
Transfusion before 
procedure 5.9 ± 2.9 6.4 ± 3.8
Laboratory findings before
procedure
Hemoglobin (g/dL) 7.6 ± 1.2 8.0 ± 1.3
Platelets (× 103/μ l) 153.2 ± 60.50 189.3 ± 67.90
Prothrombin time (%) 74.4 ± 12.8 77.9 ± 12.3
INR 1.2 ± 0.1 1.2 ± 0.2
Mortality rates 6% (1/17) 5% (1/19)
Note.─ NSAIDs = non-steroidal anti-inflammatory drugs, INR = 
international normalized ratio, group A = visualization of bleeding focus,
group B = non-visualization of bleeding focus, as determined by results of
an angiography.lend to easy access for endoscopic investigations. In our
study, 97% of patients (35 of 36) underwent a
colonoscopy for the diagnosis and management of LGI
bleeding; however, we could not treat them because of the
inability to perform an adequate inspection due to the
active bleeding and the location of the source of the
bleeding in the small bowel.
We identified 56 cases in the literature in which a
transcatheter embolization was the treatment of LGI
bleeding in the small bowel (Table 2) (6-12). The technical
success rate ranged from 40-100%, and the rebleeding
rate was 0-40%. We found two cases with major ischemic
complications; one case of fistula formation and one case
of ileal segmentectomy (6, 10). In our study, the technical
success rate was 100% and the rebleeding rate was 21%.
The choice of occlusive agents depended on the location of
the transcatheter embolization and operator preference.
Most recent investigators have used gelfoam, polyvinyl
alcohol particles (PVA), N-butyl cyanoacrylate (NBCA),
microcoils or some combination of these materials (22-24).
We preferred to use microcoils ranging in size from 3-2
mm to 4-2 mm since they are easy to see, control, and
deploy accurately. Smaller PVAs may reach the intramural
circulation, while larger PVAs may fragment upon
injection and collect at the submucosal plexus beyond the
level of collateralization (22). Gelfoam has the disadvan-
tage of being a temporary occlusive agent and it may cause
an ischemic change in the intestinal wall after distal
embolization (23). Jae et al. (24) recently reported that
transcatheter arterial embolization with NBCA is a highly
effective and safe treatment for UGI bleeding; especially if
it is not possible to advance the microcatheter to the
bleeding site or if the patient suffers with coagulopathy.
However, there no reports exist on the clinical usefulness
of NBCA in patients with LGI bleeding. 
The localization of the bleeding site by angiographic
evaluation requires the patient to be actively bleeding at
the time of the study (14). An exhaustive investigational
workup failed to identify a definitive bleeding site in some
patients, which resulted in the patients to undergo
repeated invasive investigations and blood transfusions.
Blind surgical resections of the colon for patients with
nonlocalized LGI bleeding were associated with a 33%
mortality rate in one surgical series (25). For the localiza-
tion of bleeding sites, provocative angiographic studies
with the use of intraarterial tissue plasminogen activator
(tPA), heparin and tolazoline have been reported (26, 27).
Ryan et al. (26) reported that an intraarterial provocative
mesenteric angiography with heparin, vasodilator, and tPA
identified the site of bleeding in 38% of patients and that
this contributed to the treatment for 50% of the patients.
However, in our study, all the patients with no visualized
bleeding focus underwent repeated angiography as well as
provocative testing, and received conservative manage-
ment. Only one patient (5%) died due to continuous
bleeding and multi-organ failure. This mortality rate is not
different then the mortality rate observed in the group that
underwent embolization of the bleeding focus (6%).
However, Burgess and Evans (14) reported that patients
without active bleeding identified at the time of an
angiogram had a proven ischemia rate of 60% and a 60%
mortality rate from continued bleeding or intestinal
ischemia. We thought that this difference in mortality rates
compared to the current study might be due to differences
of the underlying diseases for the study group.
Our study had some limitations; including the fact that it
was a retrospective analysis and the sample size was small.
As a result, the refinement and clinical validation of this
method requires a prospective study. A prospective,
randomized study may provide a more accurate evaluation
of the treatments for LGI bleeding with information that is
more succinct. Second, in our study, we partially diagnosed
the minor ischemic changes of the small bowel depending
on the patient’s symptoms. However, the ischemic changes
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396 Korean J Radiol 10(4), Jul/Aug 2009
Table 2. Reported Lower Gastrointestinal Tract Embolization Series with Five or More Patients with Small Bowel Bleeding 
Author (Ref) No.  Clinical Success Site Re-Bleeding Embolic Agent
Major Ischemic 
Complications
Gordon et al. (6, 1997) 08 08/8 (100%) JA (7), IA (1)  no Coil 1*
Peck et al. (7, 1998) 08 7/8 (88%) N/A 3/8 (38%)0 Gelfoam, microcoil no
Defreyne et al. (8, 2001) 05 05/5 (100%) JA (3), lA (1), ICA (1) 1/5 (20%)** PVA no
Bandi et al. (9, 2001) 06 4/6 (66%) N/A no PVA, microcoils, Gelfoam no
Waugh et al. (10, 2004) 19 19/19 (100%)0 N/A 6/27 (22%)00 PVA, microcoils, Gelfoam 1#
d’Othee et al. (11, 2005) 05 2/5 (40%) JA (3), IA (2) no Platinum Hilal microcoils no
Charbonnet et al. (12, 2005) 05 3/5 (60%) N/A 2/5 (40%)0 Silk particles, coil, PVA no
Note.─ No. = number of patients, * = fistula formation, ** = multiple lesions that required surgery, # = ileal segmentectomy, JA = jejunal artery, IA = ileal 
artery, N/A = no application, ICA = ileocolic artery, PVA = polyvinyl alcoholof the bowel require assessment by regular US and CT
examinations.
In conclusion, the superselective microcoil embolization
should be considered as a viable treatment modality for
the treatment of patients with active LGI bleeding in the
small bowel. The mortality rates are not significantly
different between the patients of the visualization and non-
visualization groups on angiography. 
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